• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Recent Advances in the Study of 4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one (CAS: 1428651-86-8)

4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one (CAS: 1428651-86-8) is a key intermediate in the synthesis of various biologically active compounds, particularly in the field of medicinal chemistry. Recent studies have highlighted its significance in the development of novel therapeutic agents targeting neurological disorders, cancer, and infectious diseases. This research briefing provides an overview of the latest findings related to this compound, focusing on its synthesis, biological activities, and potential applications.

One of the most notable advancements in the study of 4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one is its role as a precursor in the synthesis of isoquinoline derivatives. Isoquinolines are a class of heterocyclic compounds with diverse pharmacological properties, including antimicrobial, anticancer, and neuroprotective effects. Recent research has demonstrated that modifications to the isoquinoline scaffold, such as bromination at the 4-position, can significantly enhance the compound's bioactivity and selectivity.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of 4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one as a building block for the development of kinase inhibitors. The study reported that derivatives of this compound exhibited potent inhibitory activity against specific kinases involved in cancer cell proliferation. The findings suggest that 4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one could serve as a valuable scaffold for designing next-generation anticancer drugs.

Another area of interest is the compound's potential application in neurodegenerative disease research. A recent study in ACS Chemical Neuroscience investigated the neuroprotective effects of isoquinoline derivatives synthesized from 4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one. The results indicated that these derivatives could mitigate oxidative stress and inflammation in neuronal cells, offering a promising avenue for the treatment of conditions such as Alzheimer's and Parkinson's diseases.

From a synthetic chemistry perspective, advancements have been made in optimizing the production of 4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one. A 2022 publication in Organic Process Research & Development detailed a scalable and cost-effective method for its synthesis, emphasizing the use of green chemistry principles. This development is particularly significant for industrial applications, where efficient and sustainable production methods are highly sought after.

In conclusion, 4-bromo-5,6,7,8-tetrahydroisoquinolin-8-one (CAS: 1428651-86-8) continues to be a compound of great interest in the field of medicinal chemistry. Its versatility as a synthetic intermediate and its potential therapeutic applications make it a focal point for ongoing research. Future studies are expected to further elucidate its mechanisms of action and explore its utility in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)